EUVIMEDEUVIMED entdecken
Open Access

Real-Time Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control: Clinical and Economic Impact

Alexander J Sundermann iD, Praveen Kumar iD, Marissa P Griffith, Kady D Waggle, Vatsala Rangachar Srinivasa, Nathan Raabe iD, Emma G Mills, Hunter Coyle iD, Deena Ereifej, Hannah M Creager, Ashley Ayres, Daria Van Tyne iD und 4 weitere

Clinical Infectious Diseases · 09.02.2026 · 82 (1) · 134-141

DOI: 10.1093/cid/ciaf216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 30.04.2025. Verfasst von Alexander J Sundermann und 15 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Genomic Epidemiology Laboratory, Center for Genomic Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Disease Outbreaks, Cross Infection, Infection Control. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current methods are insufficient alone for outbreak detection in hospitals. Real-time genomic surveillance offers the potential to detect otherwise unidentified outbreaks. We initiated and evaluated the Enhanced Detection System for Healthcare-associated Transmission (EDS-HAT), a real-time genomic surveillance program for outbreak detection and mitigation.

Methods

This study was conducted at UPMC Presbyterian Hospital from November 2021 to October 2023. Whole genome sequencing (WGS) was performed weekly on healthcare-associated clinical bacterial isolates to identify otherwise undetected outbreaks. IP&C interventions were implemented in real-time based on identified transmission. A clinical and economic impact analysis was conducted to estimate infections avoided and net cost savings.

Results

There were 3921 bacterial isolates from patient healthcare-associated infections that underwent WGS, of which 476 (12.1%) clustered into 172 outbreaks (size 2–16 patients). Of the outbreak isolates, 292 (61.3%) had an identified epidemiological link. Among the outbreaks with interventions, 95.6% showed no further transmission on the intervened transmission route. The impact analysis estimated that, over the 2-year period, 62 infections and 4.8 deaths were avoided, with gross cost savings of $1,011,146, and net savings of $695,706, which translates to a 3.2-fold return on investment. Probabilistic sensitivity analysis showed EDS-HAT was cost saving and more effective in 98% of simulations.

Conclusions

Real-time genomic surveillance enabled the rapid detection and control of outbreaks in our hospital and resulted in patient and economic benefits. This study demonstrates the feasibility and effectiveness of integrating genomic surveillance into routine infection prevention practice, offering a paradigm shift in healthcare outbreak detection and control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease OutbreaksCross InfectionInfection ControlHumansWhole Genome SequencingGenomicsEpidemiological Monitoring

Stichwörter der Autor:innen

genomic surveillancehealthcare-associated infectionsoutbreaksurveillancewhole genome sequencing

Autor:innen und Institutionen

  • Microbial Genomic Epidemiology Laboratory, Center for Genomic Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Health Policy and Management, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Infection Control and Hospital Epidemiology, UPMC Presbyterian, Pittsburgh, Pennsylvania, USA.
  • Department of Pathology, UPMC, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Alexander J Sundermann, Praveen Kumar, Nathan Raabe, Hunter Coyle, Daria Van Tyne, Graham M Snyder

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Sundermann, A. J., Kumar, P., Griffith, M. P., Waggle, K. D., Rangachar Srinivasa, V., Raabe, N., Mills, E. G., Coyle, H., Ereifej, D., Creager, H. M., Ayres, A., Van Tyne, D., Pless, L. L., Snyder, G. M., Roberts, M., & Harrison, L. H. (2026). Real-Time Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control: Clinical and Economic Impact. Clinical Infectious Diseases, 82(1), 134-141. https://doi.org/10.1093/cid/ciaf216

Vancouver

Sundermann AJ, Kumar P, Griffith MP, Waggle KD, Rangachar Srinivasa V, Raabe N, et al. Real-Time Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control: Clinical and Economic Impact. Clinical Infectious Diseases. 2026;82(1):134-141. doi:10.1093/cid/ciaf216

BibTeX
@article{Sundermann2026,
  author = {Sundermann, Alexander J and Kumar, Praveen and Griffith, Marissa P and Waggle, Kady D and Rangachar Srinivasa, Vatsala and Raabe, Nathan and Mills, Emma G and Coyle, Hunter and Ereifej, Deena and Creager, Hannah M and Ayres, Ashley and Van Tyne, Daria and Pless, Lora Lee and Snyder, Graham M and Roberts, Mark and Harrison, Lee H},
  title = {Real-Time Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control: Clinical and Economic Impact},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {82},
  number = {1},
  pages = {134--141},
  doi = {10.1093/cid/ciaf216}
}
Kostenlos starten →